Pure Global
NCT06419530

A Study on Probiotic Formula in Autistic Children

A Double-blind Randomized Clinical Trail Study on the Effectiveness and Safety of Probiotic Formula in Autistic Children With Gastrointestinal Symptoms
Third Military Medical University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Autism Spectrum Disorder
Drug/Device/Intervention
Probiotic formula capsule
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Third Military Medical University
Location
Chongqing, China
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 01, 2028
Enrollment
156 participants
Primary outcome

Changes in Behavioral Rating Scale (ABC) scores of children with autism in 12th week and baseline

Summary

A Randomized controlled double-blind clinical study on the effectiveness and safety of
 probiotic formula in Autistic children with gastrointestinal symptoms.

ICD-10 classifications
Childhood autismAtypical autismAsperger syndromeNeurotic disorder, unspecifiedMental and behavioural disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06419530
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06419530 through Pure Global AI's free database. This phase not specified trial is sponsored by Third Military Medical University and is currently Not yet recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 156 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.